Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Markers of kidney tubule dysfunction and injury and long-term risk of acute kidney injury following coronary artery bypass graft surgery.

PloS one·2026
Same author

Estradiol protects kidney tubules against ferroptosis.

Kidney international·2026
Same author

Current evidence and future directions for KIM-1 as a blood-based biomarker in RCC.

Nature reviews. Clinical oncology·2026
Same author

Implementing virtual reality for emergency training in nephrology: a large-scale study on educational impact and acceptance.

Clinical kidney journal·2026
Same author

Missing data in ecology: Syntheses, clarifications, and considerations.

Ecological monographs·2026
Same author

National Institutes of Health Workshop to Accelerate Therapeutic Innovation by Optimizing Kidney Precision Medicine Clinical Trials.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same journal

Regression analysis of misclassified current status data with potentially unknown test accuracy.

Statistical methods in medical research·2026
Same journal

Bayesian multivariate linear mixed-effects models with varied association structures.

Statistical methods in medical research·2026
Same journal

Inference about the ratio of age-standardized rates between two overlapping populations.

Statistical methods in medical research·2026
Same journal

A robust neural network with random effects for subject-specific prediction of clustered count data.

Statistical methods in medical research·2026
Same journal

A comparison of methods for designing hybrid type 2 cluster-randomized trials with continuous effectiveness and implementation endpoints.

Statistical methods in medical research·2026
Same journal

Joint analysis of longitudinal and recurrent event data: A functional regression approach with autoregressive frailty.

Statistical methods in medical research·2026
See all related articles

Related Experiment Video

Updated: Mar 7, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K

Biomarker validation with an imperfect reference: Issues and bounds.

Sarah C Emerson1, Sushrut S Waikar2, Claudio Fuentes1

  • 11 Department of Statistics, Oregon State University, Corvallis, OR, USA.

Statistical Methods in Medical Research
|February 8, 2017
PubMed
Summary
This summary is machine-generated.

Evaluating new biomarkers for acute kidney injury is challenging without a gold standard. This study shows reference test errors bias new biomarker assessments, but bounds can still offer useful performance insights.

Keywords:
Biomarkersconditional independencediagnostic testsimperfect referencesensitivityspecificity

More Related Videos

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.4K
Rup (RNA-seq Usability Assessment Pipeline) - Quality Control for Bulk RNA-seq Experiments in Eukaryotes
05:07

Rup (RNA-seq Usability Assessment Pipeline) - Quality Control for Bulk RNA-seq Experiments in Eukaryotes

Published on: November 7, 2025

470

Related Experiment Videos

Last Updated: Mar 7, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.4K
Rup (RNA-seq Usability Assessment Pipeline) - Quality Control for Bulk RNA-seq Experiments in Eukaryotes
05:07

Rup (RNA-seq Usability Assessment Pipeline) - Quality Control for Bulk RNA-seq Experiments in Eukaryotes

Published on: November 7, 2025

470

Area of Science:

  • Biomarker discovery and validation
  • Diagnostic test evaluation
  • Medical statistics

Background:

  • Assessing new biomarkers for acute kidney injury (AKI) is crucial but difficult without a definitive gold standard.
  • Existing methods often rely on imperfect reference tests, introducing potential bias in performance evaluation.
  • Latent class analysis and similar techniques use strong, often unverifiable assumptions.

Purpose of the Study:

  • To investigate the impact of reference test errors on new biomarker performance assessment.
  • To analyze the conditional independence assumption in biomarker evaluation.
  • To establish bounds for the true sensitivity and specificity of a new biomarker.

Main Methods:

  • Exploration of the conditional independence assumption in statistical models for biomarker assessment.
  • Analysis of information content derived from comparing a new biomarker with a reference test.
  • Derivation of bounds for sensitivity and specificity using known reference test operating characteristics.

Main Results:

  • Conditional independence is only feasible within a limited range of disease prevalence values for observed data.
  • Bounds for the new biomarker's sensitivity and specificity can be derived.
  • The utility of these bounds varies, being tight and informative in some scenarios and wide in others.

Conclusions:

  • Reference test inaccuracies significantly bias new biomarker evaluations.
  • While bounds for sensitivity and specificity can be informative, their width depends on the data and reference test performance.
  • Careful consideration of assumptions and potential biases is necessary when evaluating biomarkers without a gold standard.